These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 18176340)
21. Safety, pharmacokinetics, and pharmacodynamics of S-(-)-pantoprazole sodium injections after single and multiple intravenous doses in healthy Chinese subjects. Jiao HW; Sun LN; Li YQ; Yu L; Zhang HW; Wang MF; Yu LY; Yuan ZQ; Xie LJ; Chen J; Meng L; Zhang XH; Wang YQ Eur J Clin Pharmacol; 2018 Mar; 74(3):257-265. PubMed ID: 29167917 [TBL] [Abstract][Full Text] [Related]
22. Correlation between chronic treatment with proton pump inhibitors and bacterial overgrowth in the stomach: any possible beneficial role for selected lactobacilli? Del Piano M; Pagliarulo M; Tari R; Carmagnola S; Balzarini M; Lorenzini P; Pane M J Clin Gastroenterol; 2014; 48 Suppl 1():S40-6. PubMed ID: 25291126 [TBL] [Abstract][Full Text] [Related]
23. Oral esomeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects. Armstrong D; Bair D; James C; Tanser L; Escobedo S; Nevin K Aliment Pharmacol Ther; 2003 Oct; 18(7):705-11. PubMed ID: 14510744 [TBL] [Abstract][Full Text] [Related]
24. Equipotent inhibition of gastric acid secretion by equal doses of oral or intravenous pantoprazole. Hartmann M; Ehrlich A; Fuder H; Lühmann R; Emeklibas S; Timmer W; Wurst W; Lücker PW Aliment Pharmacol Ther; 1998 Oct; 12(10):1027-32. PubMed ID: 9798809 [TBL] [Abstract][Full Text] [Related]
25. Use of polymerase chain reaction techniques and sodium dodecyl sulfate-polyacrylamide gel electrophoresis for differentiation of oral Lactobacillus species. Teanpaisan R; Dahlén G Oral Microbiol Immunol; 2006 Apr; 21(2):79-83. PubMed ID: 16476016 [TBL] [Abstract][Full Text] [Related]
26. Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study. Vicariotto F; Mogna L; Del Piano M J Clin Gastroenterol; 2014; 48 Suppl 1():S106-12. PubMed ID: 25291116 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of intravenous administration of combined acid suppressants in healthy dogs. Tolbert MK; Odunayo A; Howell RS; Peters EE; Reed A J Vet Intern Med; 2015; 29(2):556-60. PubMed ID: 25711717 [TBL] [Abstract][Full Text] [Related]
28. Prospective, randomized trial comparing effect of oral versus intravenous pantoprazole on rebleeding after nonvariceal upper gastrointestinal bleeding: a pilot study. Bajaj JS; Dua KS; Hanson K; Presberg K Dig Dis Sci; 2007 Sep; 52(9):2190-4. PubMed ID: 17429726 [TBL] [Abstract][Full Text] [Related]
29. Negative Effect of Proton-pump Inhibitors (PPIs) on Helicobacter pylori Growth, Morphology, and Urease Test and Recovery after PPI Removal--An In vitro Study. Saniee P; Shahreza S; Siavoshi F Helicobacter; 2016 Apr; 21(2):143-52. PubMed ID: 26222264 [TBL] [Abstract][Full Text] [Related]
30. Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against Helicobacter pylori. Nakao M; Malfertheiner P Helicobacter; 1998 Mar; 3(1):21-7. PubMed ID: 9546114 [TBL] [Abstract][Full Text] [Related]
31. Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily. Bardhan KD; Dillon J; Axon AT; Cooper BT; Tildesley G; Wyatt JI; Gatz G; Braun W Aliment Pharmacol Ther; 2000 Jan; 14(1):59-67. PubMed ID: 10632646 [TBL] [Abstract][Full Text] [Related]
32. Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders. Cheer SM; Prakash A; Faulds D; Lamb HM Drugs; 2003; 63(1):101-33. PubMed ID: 12487624 [TBL] [Abstract][Full Text] [Related]
33. Pantoprazole: from drug metabolism to clinical relevance. Bardou M; Martin J Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):471-83. PubMed ID: 18433349 [TBL] [Abstract][Full Text] [Related]
34. Proton pump activation in stimulated parietal cells is regulated by gastric acid secretory capacity: a human study. Metz DC; Ferron GM; Paul J; Turner MB; Soffer E; Pisegna JR; Bochenek WJ J Clin Pharmacol; 2002 May; 42(5):512-9. PubMed ID: 12017345 [TBL] [Abstract][Full Text] [Related]
36. Intragastric acidity after switching from 5-day treatment with intravenous pantoprazole 40 mg/d to 5-day treatment with oral esomeprazole 40 mg/d or pantoprazole 40 mg/d: an open-label crossover study in healthy adult volunteers. Miner PB; Tutuian R; Castell DO; Liu S; Sostek MB Clin Ther; 2006 May; 28(5):725-33. PubMed ID: 16861094 [TBL] [Abstract][Full Text] [Related]
37. Relative efficacies of gastric proton-pump inhibitors on a milligram basis: desired and undesired SH reactions. Impact of chirality. Kromer W Scand J Gastroenterol Suppl; 2001; (234):3-9. PubMed ID: 11768559 [TBL] [Abstract][Full Text] [Related]
38. Pantoprazole available without a prescription: new status. Better than H2 receptor agonists, but not for pregnant women. Prescrire Int; 2009 Dec; 18(104):250. PubMed ID: 20025090 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and pharmacodynamics of pantoprazole in clinically normal neonatal foals. Ryan CA; Sanchez LC; Giguère S; Vickroy T Equine Vet J; 2005 Jul; 37(4):336-41. PubMed ID: 16028623 [TBL] [Abstract][Full Text] [Related]